Search results
Anebulo (ANEB) Gains on Positive FDA Response for ANEB-001
Zacks via Yahoo News· 10 months agoAnebulo (ANEB) gains on positive FDA response for the phase III development of its lead candidate...
Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001
Zacks via Yahoo News· 1 year agoTimber (TMBR) receives a dermal carcinogenicity waiver from the FDA for TMB-001, which is being...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo News· 4 weeks agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Eli Lilly (LLY) Gets FDA Nod for RET Inhibitor in Solid Tumors
Zacks via Yahoo News· 2 years agoThe FDA grants approval to Lilly's (LLY) Retevmo in advanced or metastatic solid tumors with a RET...
Kintara (KTRA) Rises 41% on $2M Grant for Breast Cancer Therapy
Zacks via Yahoo News· 1 year agoKintara (KTRA) receives a $2 million grant from the National Institutes of Health to develop its...
Adicet (ACET) Stock Rallies 130% in a Month: Here's Why
Zacks via Yahoo News· 6 months agoAdicet Bio ACET, a clinical-stage company, develops “off-the-shelf” gamma delta T cell therapies...
Stoke Therapeutics (STOK) Up on Upbeat Dravet Syndrome Study Data
Zacks via Yahoo News· 3 months agoStoke Therapeutics, Inc. STOK reported encouraging new data from two phase I/IIa studies and two...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo News· 11 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Akero Therapeutics (AKRO) Up on Positive Data from NASH Study
Zacks via Yahoo News· 2 years agoAkero Therapeutics (AKRO) reports positive top-line data from a mid-stage study evaluating its lead...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo News· 2 weeks agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...